Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Circulating tumor cells (CTCs) five years after diagnosis are prognostic for late recurrence in operable stage II-III breast cancer Sparano, J. A., O'Neill, A., Alpaugh, K., Wolff, A. C., Northfelt, D. W., Dang, C., Sledge, G. W., Miller, K. D. AMER ASSOC CANCER RESEARCH. 2018
View details for Web of Science ID 000425489400039